208 related articles for article (PubMed ID: 5964006)
21. [Studies of the live AMN USSR measles vaccine from the ESC strain and its use and problems of mass vaccinations against measles].
Czumakow MP; Woroszylowa MK; Graczew WP; Sinjak KM; Bojko WM; Sejbil WB; Rodin WI; Piwień GG
Przegl Epidemiol; 1970; 24(2):205-11. PubMed ID: 5431794
[No Abstract] [Full Text] [Related]
22. Measles immunity after revaccination: results in children vaccinated before 10 months of age.
Linnemann CC; Dine MS; Roselle GA; Askey PA
Pediatrics; 1982 Mar; 69(3):332-5. PubMed ID: 7063289
[TBL] [Abstract][Full Text] [Related]
23. Immune response to measles vaccine in Peruvian children.
Bautista-López NL; Vaisberg A; Kanashiro R; Hernández H; Ward BJ
Bull World Health Organ; 2001; 79(11):1038-46. PubMed ID: 11731811
[TBL] [Abstract][Full Text] [Related]
24. [Results of the inoculation test of measles vaccine. 1. The result of measles-attenuated live virus vaccine].
Santo K
Nihon Shonika Gakkai Zasshi; 1967 Mar; 71(3):332-43. PubMed ID: 4168846
[No Abstract] [Full Text] [Related]
25. Studies on further attenuated live measles vaccine. 3. Selection of less reactive variants of CAM measles vaccine virus.
Takaku K; Sasada T; Konobe T; Onishi K; Ueda S
Biken J; 1970 Sep; 13(3):163-8. PubMed ID: 5530510
[No Abstract] [Full Text] [Related]
26. [Clinical and immunological prospective study of the measles live virus vaccine].
Sujoy E; Blaksley JC; Shepherd G; Simsolo V; Palais L; Pizzia A; Becker D; Behar M; Morgenstern O
Arch Argent Pediatr; 1966; 63(7):260-5. PubMed ID: 5990418
[No Abstract] [Full Text] [Related]
27. [Clinico-immunological characteristics of measles in children vaccinated with a live measles vaccine].
Smorodinova IP; Shikina ES
Tr Leningr Nauchnoissled Inst Epidemiol Mikrobiol; 1973; 42():102-8. PubMed ID: 4808371
[No Abstract] [Full Text] [Related]
28. Measles vaccination during the respiratory virus season and risk of vaccine failure.
Edmonson MB; Davis JP; Hopfensperger DJ; Berg JL; Payton LA
Pediatrics; 1996 Nov; 98(5):905-10. PubMed ID: 8909484
[TBL] [Abstract][Full Text] [Related]
29. [Study on the long-term observation of measles vaccine immunity. 1. End results of vaccination and re-vaccination].
Tsukada Y
Nihon Shonika Gakkai Zasshi; 1968 Apr; 72(4):473-87. PubMed ID: 5692409
[No Abstract] [Full Text] [Related]
30. Studies on the combined use of killed and live measles vaccines. II. Advantages of the inhalation method.
Okuno Y; Ueda S; Hosai H; Kitawaki T; Nakamura K; Chiang TP; Okabe S; Onaka M; Toyoshima K
Biken J; 1965 Jun; 8(2):81-5. PubMed ID: 5837767
[No Abstract] [Full Text] [Related]
31. [Experience with preventive measles, mumps and rubella vaccination in unified Germany].
Gerike E; Tischer A
Gesundheitswesen; 1993 Jan; 55(1):38-9. PubMed ID: 8435543
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of the live AIK measles virus vaccine.
Makino S; Sasaki K; Nakamura N; Nakagawa M; Nakajima S
Kitasato Arch Exp Med; 1973 Dec; 46(3-4):83-92. PubMed ID: 4805362
[No Abstract] [Full Text] [Related]
33. Measles and measles vaccination in isolated Amerindian tribes. II. The 1978/79 Xingu epidemic.
Baruzzi RG; Abdala N; Black FL
Trop Geogr Med; 1982 Mar; 34(1):7-12. PubMed ID: 7080192
[TBL] [Abstract][Full Text] [Related]
34. A study of the protective effect of live measles vaccines 13 to 27 months after vaccination.
Sejda J; Helcl J; Strauss J; Zdrazílek J; Mírovský J
J Hyg Epidemiol Microbiol Immunol; 1968; 12(2):187-91. PubMed ID: 5752748
[No Abstract] [Full Text] [Related]
35. [Specific anti-measles prophylaxis in Rumania. 3. Comparative study of some live attenuated virus vaccines].
Cajal N; Cepleanu M; Cernescu C; Sorodoc Y
Stud Cercet Inframicrobiol; 1969; 20(4):275-85. PubMed ID: 5371258
[No Abstract] [Full Text] [Related]
36. [Results of the inoculation test of measles vaccine. 2. The results of the use of inactivated measles vaccine alone and combined inactivated and attenuated live virus vaccine].
Santo K
Nihon Shonika Gakkai Zasshi; 1967 Mar; 71(3):344-55. PubMed ID: 6070597
[No Abstract] [Full Text] [Related]
37. [Time of the appearance of immunity to measles after the administration of a live measles vaccine].
Revenok ND
Tr Leningr Nauchnoissled Inst Epidemiol Mikrobiol; 1965; 28():355-60. PubMed ID: 5860953
[No Abstract] [Full Text] [Related]
38. [Specific features of measles in vaccinated children].
Loseva AG; Peĭzner EM
Vopr Okhr Materin Det; 1978 Sep; 23(9):49-50. PubMed ID: 716292
[No Abstract] [Full Text] [Related]
39. [Experience of a vaccination campaign using the Edmoston Zagreb strain (EZ 19) coinciding with reports about numerous cases of measles in the USL 23 region of Arezzo].
Rossi PL; Poggini G; Bagianti C; Giglio E; Piergiovanni MG; Maruccia T; Pisano G
Clin Ter; 1993 Apr; 142(4):335-40. PubMed ID: 8330476
[TBL] [Abstract][Full Text] [Related]
40. [Data for the evaluation of the epidemiological effectiveness of a live measles vaccine prepared from the Leningrad-4 strain].
Nikitin MIa; Kozlova NA; Kulikova VA; Malafeeva LK; Petrova TN
Tr Leningr Nauchnoissled Inst Epidemiol Mikrobiol; 1965; 28():309-20. PubMed ID: 5893106
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
